Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
430.06B | 422.67B | 406.45B | 398.37B | 408.96B | 433.55B | Gross Profit |
75.45B | 68.83B | 53.29B | 46.08B | 21.09B | 25.44B | EBIT |
28.76B | 23.31B | 9.88B | 1.77B | -29.18B | -36.47B | EBITDA |
29.72B | 27.97B | 16.46B | 11.13B | -18.76B | -24.45B | Net Income Common Stockholders |
42.58B | 42.06B | 19.81B | 11.85B | -23.68B | -80.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
78.15B | 68.63B | 53.56B | 45.72B | 54.96B | 66.45B | Total Assets |
204.04B | 205.00B | 166.55B | 145.43B | 161.71B | 196.95B | Total Debt |
30.77B | 30.88B | 31.85B | 33.04B | 35.41B | 36.13B | Net Debt |
-47.28B | -37.75B | -21.71B | -12.48B | -19.46B | -24.37B | Total Liabilities |
121.16B | 133.32B | 133.63B | 134.40B | 158.43B | 195.36B | Stockholders Equity |
76.41B | 64.15B | 24.40B | 1.43B | -8.11B | 1.57B |
Cash Flow | Free Cash Flow | ||||
0.00 | 21.10B | 9.94B | -5.95B | -43.65B | -55.38B | Operating Cash Flow |
0.00 | 21.42B | 10.54B | -4.46B | -40.82B | -51.64B | Investing Cash Flow |
0.00 | 851.00M | 906.00M | 886.00M | 11.83B | 39.53B | Financing Cash Flow |
0.00 | -7.12B | -2.82B | -5.89B | 23.57B | -12.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€1.25B | 11.30 | 24.21% | 1.59% | ― | ― | ||
64 Neutral | $12.86B | 9.79 | 7.78% | 16985.65% | 12.28% | -7.82% | |
$1.15B | 11.49 | 13.76% | 2.60% | ― | ― | ||
$1.24B | 20.23 | 21.92% | 2.29% | ― | ― | ||
$681.90M | 7.37 | 14.51% | 3.10% | ― | ― | ||
81 Outperform | ¥185.54B | 12.74 | 2.39% | 8.04% | 167.85% | ||
67 Neutral | ¥70.16B | 16.69 | 2.67% | 1.42% | 15.98% |